Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2022

May 24, 2022

32853_dirs_2022-05-23_b815585a-5623-425d-b6df-e60893a88a03.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-05-20

Reporting Person: Khadder Nicholas (SVP, Gen. Counsel & Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-05-20 Common Stock M 4063 Acquired 86454 Direct
2022-05-20 Common Stock M 15000 Acquired 101454 Direct
2022-05-20 Common Stock M 9846 Acquired 111300 Direct
2022-05-20 Common Stock F 14161 Disposed 97139 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-05-20 Restricted Stock Units $ M 4063 Disposed Common Stock (4063.0) Direct
2022-05-20 Restricted Stock Units $ M 15000 Disposed Common Stock (15000.0) Direct
2022-05-20 Restricted Stock Units $ M 9846 Disposed Common Stock (9846.0) Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F2: On May 23, 2020, the Reporting Person was granted 65,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

F3: On May 23, 2020, the Reporting Person was granted 60,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023.

F4: On April 20, 2021, the Reporting Person was granted 39,387 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.